SprosRadar
Find tenders
SprosRadar
Find tenders
Tenders Electronic Daily (TED) · 788501-2026

77454 Voluntary ex ante transparency notice

Key facts

StatusAwarded
Estimated valueValue not published
Submission deadlineDeadline not published
PublishedNov 12, 2026
BuyerOslo Universitetssykehus HF (hovedenhet)
CountryNorway · OSLO
CPV code33000000, 38000000
SourceTenders Electronic Daily (TED) ↗
Open official notice
Status
Awarded
Estimated value
Value not published
Submission deadline
Deadline not published
Published
Nov 12, 2026
Buyer
Oslo Universitetssykehus HF (hovedenhet)
Country
Norway
CPV code
33000000, 38000000
Source
Tenders Electronic Daily (TED)

Contract outcome & evergreen alternatives

This notice is no longer open for submissions. The original remains available for reference.

Awarded supplier / winnerRegistration / LEI numberCountryAwarded contract amountAward date
Cytiva Europe GMBH NUF
Tyristrand, 3533		NO-BRREG: 968146092NorwayValue not publishedNov 12, 2026

Open tenders in this CPV category (CPV 33000000 · View CPV × country award matrix)

Checked:

The original notice takes precedence. Its status and conditions can change after collection.

Description

77454 RA KRE – Cell processing equipment (Sepax C-Pro) with consumables and service – notice of intention to award a contract without prior publication of a call for competition Oslo University Hospital (OUS) intends to award a contract to Cytiva Europe GmbH, Norwegian Branch (filial Norge), for the purchase of one cell processing instrument (Sepax C-Pro) as a back-up for the existing validated instrument at the Section for Cell Therapy, Radiumhospitalet. The contract also includes a framework agreement for proprietary consumables (single-use kits) and service. The estimated total value is NOK 8.0 million excl. VAT over 10 years, and covers the instrument, consumables and service. Justification for the choice of procedure The contract is awarded without prior publication of a call for competition pursuant to Section 13-4, letter b, no. 2 of the Norwegian Public Procurement Regulations (anskaffelsesforskriften). The full justification is set out in the attached document “Justification for the award of a contract without prior publication of a call for competition”, dated 11 November 2026. Any objections must be submitted in writing to the contact person via Mercell within 10 days after publication of the notice.

Lots

  1. 77454 Voluntary ex ante transparency notice

    77454 RA KRE – Cell processing equipment (Sepax C-Pro) with consumables and service – notice of intention to award a contract without prior publication of a call for competition Oslo University Hospital (OUS) intends to award a contract to Cytiva Europe GmbH, Norwegian Branch (filial Norge), for the purchase of one cell processing instrument (Sepax C-Pro) as a back-up for the existing validated instrument at the Section for Cell Therapy, Radiumhospitalet. The contract also includes a framework agreement for proprietary consumables (single-use kits) and service. The estimated total value is NOK 8.0 million excl. VAT over 10 years, and covers the instrument, consumables and service. Justification for the choice of procedure The contract is awarded without prior publication of a call for competition pursuant to Section 13-4, letter b, no. 2 of the Norwegian Public Procurement Regulations (anskaffelsesforskriften). The full justification is set out in the attached document “Justification for the award of a contract without prior publication of a call for competition”, dated 11 November 2026. Any objections must be submitted in writing to the contact person via Mercell within 10 days after publication of the notice.

Public business contacts

fse@ous-hf.no

91 50 27 70

Checked: